Company Overview and News

 
The Lost Decade of Sentosa Cove, Singapore's Billionaire Haven

2018-09-18 theedgemarkets
(Sept 19): Sentosa Cove, a residential enclave nestled on an island off the coast of Singapore, is quiet at the best of times. Of a weekday, its frangipani-lined streets are mostly devoid of life, save the odd domestic helper taking her four-legged charge out for a walk.
CBG CBRE

12
8 GARP Stocks to Scoop Up for Maximum Returns

2018-09-18 zacks
Growth at a reasonable price or GARP is an excellent way for investors to make some quick gains. This strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. The GARP approach leads to the identification of stocks that are priced below the market or any reasonable target determined by fundamental analysis. These stocks also have solid prospects in terms of cash flow, revenues, earnings per share (EPS) and so on.
AFW TXN AFGE AFA MDP AFGH EME TER AFG CBG LAZ MDPEB CI MXIM CBRE CE

 
CBRE or RMAX: Which Is the Better Value Stock Right Now?

2018-09-17 zacks
Investors looking for stocks in the Real Estate - Operations sector might want to consider either CBRE Group (CBRE - Free Report) or RE/MAX (RMAX - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
CBG CBRE

 
Prologis Tackles Labor Shortage Concerns With CWI Program

2018-09-14 zacks
Industrial REIT Prologis Inc. (PLD - Free Report) has rolled out the Prologis Community Workforce Initiative (CWI), and a Southern California non-profit organization — EXP — has been signed as the first CWI partner of the former. This move comes amid e-commerce boom, growth of the logistic real estate market at a substantial pace, while shortage of labor remains a pressing concern. The initiative involves the company’s partnership with local workforce programs in order to offer mentorship, skills training and internships, as well as job-placement services for people interested in building their careers in the logistics, distribution and transportation sectors.
PLD CY CBG DRE LPT CBRE

 
CBG / CBRE Group, Inc. 8-K (Current Report)

2018-09-11 sec.gov
cbg-8k_20180911.htm UNITED STATES
CBG

3
EastGroup (EGP) Cheers Investors with 12.5% Dividend Hike

2018-09-10 zacks
Ushering in good news for its shareholders, EastGroup Properties (EGP - Free Report) announced a 12.5% hike in the company's quarterly dividend rate to 72 cents per share from 64 cents paid earlier. The new dividend is scheduled to be paid on Oct 15, to shareholders of record as of Sep 28, 2018. Based on the increased rate, the annual dividend comes to $2.88 per share, up from the previous annual rate of $2.
DRE PLDGP BRK.A PLD CBG CBRE EGP

7
Should You Add CBRE Group (CBRE) Stock to Your Portfolio Now?

2018-09-10 zacks
CBRE Group (CBRE - Free Report) has a robust scale as the largest commercial real estate services and investment firm (based on 2017 revenues). It is among the few companies offering a full suite of services to multi-national clients. Moreover, the company has grown organically, and banked on strategic acquisitions to boost its service offerings and geographic reach. Most recently, the company announced the acquisition of a consulting firm focused on serving healthcare facility owners named Noveen Consulting.
DWHHF CIG DTCWY CIGI PSB BRK.A CBG KO CBRE

5
Top Research Reports for Abbott, Gilead & FedEx

2018-09-07 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott (ABT), Gilead (GILD) and FedEx (FDX). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
NRGEO NRG CHTR CBG UPS KHC FDX CBRE

1
Add These 5 Stocks With Impressive Interest Coverage Ratio

2018-09-07 zacks
We often judge a company on the basis of its sales and earnings numbers. These, however, may not be enough. Sometimes, a stock gets a boost if these numbers climb year over year or surpass estimates in a particular quarter. This will definitely be a great opportunity for an investor with a shorter horizon to cash in on. But if you seek long-term returns, investments backed only by sales and earnings numbers may not yield the desired results.
DECK HII CBG ALLY BJRI WCG CBRE OUT

9
3 Discount Stocks Mirror Industry Strength, Hit 52-Week Highs

2018-09-06 zacks - 1
U.S. economy paints a rosy picture, buoyed by an 18-year high consumer confidence, increasing consumer spending and strengthening labor market as well as higher business investments and government expenditure. A favorable GDP growth rate further inspires optimism. Per the Bureau of Economic Analysis, second-quarter 2018 GDP expanded 4.2% in its second estimate. This marks an improvement from 4.1% growth reported in July and 2.
TGT BURL CBG DG KHC CBRE

8
CBRE Group on Acquisition Spree, Buys Noveen Consulting

2018-09-06 zacks
CBRE Group Inc. (CBRE - Free Report) is on an acquisition spree. Recently, the company announced the acquisition of a consulting firm focused on serving healthcare facility owners named Noveen Consulting. Prior to that, CBRE Group announced the buyout of CB Richard Ellis-N.E. Partners, L.P. (CBRE/New England). It was a joint venture with Whittier Partners Group and the largest full-service commercial real estate services operation in New England.
SWX DWHHF CBG GPN KHC CIG DTCWY CIGI CBRE

8
The Howard Hughes Buys Two Office Buildings in The Woodlands

2018-09-06 zacks
The Howard Hughes Corporation (HHC - Free Report) recently announced the acquisition of two Class-A office buildings in the 28,000-acre master-planned community of The Woodlands. The acquisition deal also includes excess land where The Howard Hughes has scope to build another office building. The purchase was made in an off-market transaction for $53 million. The vacant four- and six-story buildings comprise 257,025 square feet of rentable space and are located next to the company’s Hughes Landing Development.
SWX HHC CBG GPN KHC CIG CIGI CBRE

 
High Demand Keeps Liberty's Richmond, Norfolk Assets Occupied

2018-09-05 zacks
Liberty Property Trust (LPT - Free Report) has been experiencing demand for its Richmond and Norfolk portfolios, lately. Majority of this demand is rising from the existing tenants who prefer to stay at the company’s properties over relocating to other locations. Particularly, in the first half of the year, 17 leases were executed that helped the company enjoy full occupancy at these portfolios. With majority of those being renewal agreements, the leases aggregated more than 750,000 square feet of space.
DRE PLDGP PLD CBG LPT CBRE

11
Zacks.com highlights: Celgene, Progressive, CBRE Group, NRG Energy and Celanese

2018-09-05 zacks
Chicago, IL – September 5, 2018 - Stocks in this week’s article include: Celgene Corp. (CELG - Free Report) , The Progressive Corp. (PGR - Free Report) , CBRE Group, Inc. (CBRE - Free Report) , NRG Energy, Inc. (NRG - Free Report) and Celanese Corp. (CE - Free Report) .
HLX MACK CELGZ ATH PGR WTW RUSHA NRGEO NRG RUSHB HII CBG CELG ADVM AMWD CBRE CE SOI

2
Top 5 ROE Picks as Trade Dispute With China & Canada Lingers

2018-09-04 zacks
The U.S. equity markets snapped its recent winning streak as President Trump decided to impose tariffs on $200 billion worth of imported goods from China. To add to the woes, U.S. negotiations with Canada fell flat as both the parties missed the Friday deadline to script a renewed NAFTA deal. While Trump has threatened to redraw the tripartite trade deal to a bilateral agreement centered around Mexico, Canada has also made it clear that it would not sign a deal until it benefits its citizens.
NRGEO NRG CBG CELGZ CELG PGR CBRE CE

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CBG / CBRE Group, Inc. on message board site Silicon Investor.

CB Richard Ellis Group, Inc. CB Richard Ellis Group, Inc. CB Richard Ellis Group, Inc. CBGI Cannabusiness Group CBGI Cannabusiness Group CBGI Cannabusiness Group
The Childrenu0027s Beverage Group (TCBG) The Childrenu0027s Beverage Group (TCBG) The Childrenu0027s Beverage Group (TCBG) Stock Lounge Picks...ITEC,TCBG,TEIM,BETTu0026NTN Stock Lounge Picks...ITEC,TCBG,TEIM,BETTu0026NTN Stock Lounge Picks...ITEC,TCBG,TEIM,BETTu0026NTN
TCBG No hype; itu0027s running. TCBG No hype; itu0027s running. TCBG No hype; itu0027s running.
CUSIP: 12504L109